stocks logo

GDRX Valuation

GoodRx Holdings Inc
$
4.680
+0.040(+0.860%)
  • Overview
  • Forecast
  • Valuation

GDRX Relative Valuation

GDRX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, GDRX is overvalued; if below, it's undervalued.

Historical Valuation

GoodRx Holdings Inc (GDRX) is now in the Fair zone, suggesting that its current forward PS ratio of 2.16 is considered Fairly compared with the five-year average of 8.38. The fair price of GoodRx Holdings Inc (GDRX) is between 1.20 to 29.58 according to relative valuation methord.
Relative Value
Fair Zone
1.20-29.58
Current Price：4.68
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
2.45
P/B
Median3y
3.13
Median5y
8.44
10.28
FCF Yield
Median3y
6.57
Median5y
4.62

Competitors Valuation Multiple

The average P/S ratio for GDRX's competitors is 1.71, providing a benchmark for relative valuation. GoodRx Holdings Inc Corp (GDRX) exhibits a P/S ratio of 2.16, which is 26.43% above the industry average. Given its robust revenue growth of 0.99%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
Revenue Growth
Market Cap
stocks logo
GDRX.O
GoodRx Holdings Inc
2.16
Average P/S: 1.71
0.99%
1.68B
stocks logo
IQ.O
iQIYI Inc
0.45
-14.18%
1.88B
stocks logo
COUR.N
Coursera Inc
1.85
6.05%
1.37B
stocks logo
ZD.O
Ziff Davis Inc
0.89
5.88%
1.35B
stocks logo
YELP.N
Yelp Inc
1.53
5.72%
2.27B
stocks logo
YALA.N
Yalla Group Ltd
3.36
12.24%
1.13B

People Also Watch

stocks logo
PRTC
PureTech Health PLC
17.550
USD
-0.62%
stocks logo
ITIC
Investors Title Co
240.680
USD
+3.26%
stocks logo
TBPH
Theravance Biopharma Inc
10.370
USD
-0.19%
stocks logo
PERI
Perion Network Ltd
9.300
USD
-1.90%
stocks logo
YRD
Yiren Digital Ltd
6.380
USD
-2.60%
stocks logo
AHG
Akso Health Group
1.361
USD
-2.79%
stocks logo
CYD
China Yuchai International Ltd
16.610
USD
+8.56%
stocks logo
ORGO
Organogenesis Holdings Inc
5.280
USD
+6.45%
stocks logo
JILL
JJill Inc
15.860
USD
+2.12%
stocks logo
ORKA
Oruka Therapeutics Inc
10.710
USD
+6.14%

FAQ

arrow icon

Is GoodRx Holdings Inc (GDRX) currently overvalued or undervalued?

GoodRx Holdings Inc (GDRX) is now in the Fair zone, suggesting that its current forward PE ratio of 28.26 is considered Fairly compared with the five-year average of 8.38. The fair price of GoodRx Holdings Inc (GDRX) is between 1.20 to 29.58 according to relative valuation methord.
arrow icon

What is GoodRx Holdings Inc (GDRX) fair value?

arrow icon

How does GDRX's valuation metrics compare to the industry average?

arrow icon

What is the current P/B ratio for GoodRx Holdings Inc (GDRX) as of May 03 2025?

arrow icon

What is the current FCF Yield for GoodRx Holdings Inc (GDRX) as of May 03 2025?

arrow icon

What is the current Forward P/E ratio for GoodRx Holdings Inc (GDRX) as of May 03 2025?

arrow icon

What is the current Forward P/S ratio for GoodRx Holdings Inc (GDRX) as of May 03 2025?